Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Day

Showing results (1161-1170 of 1,311) with videos related to

Pageof 132
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2024
Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAARTVictoria S Pelak, David F Tang-Wai, Bradley F Boeve, et al.
Elife|January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational studyPeter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Neurology|April 25, 2018
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Neurology|August 14, 2023
Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial CohortVijay K Ramanan, Jonathan Graff-Radford, Jeremy Syrjanen, et al.
Clinical Neurology and Neurosurgery|December 22, 2022
Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapyChristoph Mueller, Saskia Elben, Gregory S Day, et al.
Nature Communications|April 17, 2019
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylationMalgorzata Krajewska, Ruben Dries, Andrew V Grassetti, et al.
Neurology|April 25, 2018
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Neurology|April 2, 2021
Prospective Quantification of CSF Biomarkers in Antibody-Mediated EncephalitisGregory S Day, Melanie Y Yarbrough, Peter Körtvelyessy, et al.
Science Translational Medicine|November 1, 2013
Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastomaSamuel A Jensen, Emily S Day, Caroline H Ko, et al.
Internal Medicine Journal|March 5, 2014
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel diseaseE K Wright, J Williams, J M Andrews, et al.
Pageof 132

Showing results (1161-1170 of 1,311) with videos related to

Sort By:
Pageof 132
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2024
Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAARTVictoria S Pelak, David F Tang-Wai, Bradley F Boeve, et al.
Elife|January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational studyPeter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Neurology|April 25, 2018
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Neurology|August 14, 2023
Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial CohortVijay K Ramanan, Jonathan Graff-Radford, Jeremy Syrjanen, et al.
Clinical Neurology and Neurosurgery|December 22, 2022
Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapyChristoph Mueller, Saskia Elben, Gregory S Day, et al.
Nature Communications|April 17, 2019
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylationMalgorzata Krajewska, Ruben Dries, Andrew V Grassetti, et al.
Neurology|April 25, 2018
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Neurology|April 2, 2021
Prospective Quantification of CSF Biomarkers in Antibody-Mediated EncephalitisGregory S Day, Melanie Y Yarbrough, Peter Körtvelyessy, et al.
Science Translational Medicine|November 1, 2013
Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastomaSamuel A Jensen, Emily S Day, Caroline H Ko, et al.
Internal Medicine Journal|March 5, 2014
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel diseaseE K Wright, J Williams, J M Andrews, et al.
Pageof 132